Advanced in Interstitial Lung Disease

Dr. Lana D. Melendres-Groves

Pulmonary Medicine
Unm Medical Group Inc
2211 Lomas Blvd Ne, 
Albuquerque, NM 
Advanced in Interstitial Lung Disease
Unm Medical Group Inc
2211 Lomas Blvd Ne, 
Albuquerque, NM 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lana Melendres-Groves is a Pulmonary Medicine provider in Albuquerque, New Mexico. Dr. Melendres-Groves is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Lung Metastases, and Interstitial Lung Disease.

Her clinical research consists of co-authoring 22 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article and participated in 1 clinical trial in the study of Interstitial Lung Disease.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in NM
Hospital Affiliations
Unm Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Sky Community Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER COMMERCIAL
View 3 Less Insurance Carriers -

Locations

UNM MEDICAL GROUP INC
2211 Lomas Blvd Ne, Albuquerque, NM 87106
Other Locations
UNM MEDICAL GROUP INC
800 Bradbury Dr Se, Suite 116, Albuquerque, NM 87106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

22 Total Publications

Exploring patient preferences regarding the use of combination therapy with endothelin receptor antagonist (ERA) + phosphodiesterase-5 inhibitors (PDE5i).
Exploring patient preferences regarding the use of combination therapy with endothelin receptor antagonist (ERA) + phosphodiesterase-5 inhibitors (PDE5i).
Journal: JHLT open
Published: November 24, 2025
Similar Doctors
Distinguished in Interstitial Lung Disease
Dr. Nour A. Ass'ad
Pulmonary Medicine
Distinguished in Interstitial Lung Disease
Dr. Nour A. Ass'ad
Pulmonary Medicine

Unm Medical Group Inc

2211 Lomas Blvd Ne, 
Albuquerque, NM 
 (0.1 miles away)
505-272-2111
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nour Ass'ad is a Pulmonary Medicine provider in Albuquerque, New Mexico. Dr. Ass'ad is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Lung Metastases, and Bronchogenic Cyst.

Betty T. Chang
Advanced in Interstitial Lung Disease
Dr. Betty T. Chang
Pulmonary Medicine | Intensive Care Medicine
Advanced in Interstitial Lung Disease
Dr. Betty T. Chang
Pulmonary Medicine | Intensive Care Medicine

Unm Medical Group Inc

800 Bradbury Dr Se, Suite 116, 
Albuquerque, NM 
 (1.3 miles away)
Languages Spoken:
English
See accepted insurances

Betty Chang is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Albuquerque, New Mexico. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Systemic Sclerosis (SSc), and Lung Metastases.

Advanced in Interstitial Lung Disease
Dr. Matthew R. Montoya
Pulmonary Medicine
Advanced in Interstitial Lung Disease
Dr. Matthew R. Montoya
Pulmonary Medicine

Presbyterian Healthcare Services

5901 Harper Dr Ne, 
Albuquerque, NM 
 (5.0 miles away)
505-823-8888
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Matthew Montoya is a Pulmonary Medicine provider in Albuquerque, New Mexico. Dr. Montoya is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. His top areas of expertise are Cerebral Hypoxia, Lung Metastases, Emphysema, and Pulmonary Fibrosis. Dr. Montoya is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Melendres-Groves's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile